BioNTech SE (BNTX) Non-Current Deferred Tax Liability (2020 - 2025)
Historic Non-Current Deferred Tax Liability for BioNTech SE (BNTX) over the last 6 years, with Q3 2025 value amounting to $28.3 million.
- BioNTech SE's Non-Current Deferred Tax Liability fell 3184.94% to $28.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year decrease of 3184.94%. This contributed to the annual value of $45.3 million for FY2024, which is 607.2% up from last year.
- Latest data reveals that BioNTech SE reported Non-Current Deferred Tax Liability of $28.3 million as of Q3 2025, which was down 3184.94% from $32.3 million recorded in Q2 2025.
- BioNTech SE's 5-year Non-Current Deferred Tax Liability high stood at $107.1 million for Q2 2022, and its period low was $4.9 million during Q2 2023.
- Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $42.1 million (2023), whereas its average is $39.5 million.
- As far as peak fluctuations go, BioNTech SE's Non-Current Deferred Tax Liability soared by 3189845.92% in 2021, and later plummeted by 9542.61% in 2023.
- Over the past 5 years, BioNTech SE's Non-Current Deferred Tax Liability (Quarter) stood at $76.3 million in 2021, then tumbled by 91.71% to $6.3 million in 2022, then surged by 575.28% to $42.7 million in 2023, then grew by 6.07% to $45.3 million in 2024, then crashed by 37.56% to $28.3 million in 2025.
- Its Non-Current Deferred Tax Liability stands at $28.3 million for Q3 2025, versus $32.3 million for Q2 2025 and $46.4 million for Q1 2025.